Becton Dickinson & Company
Exchange: NYSESector: HealthcareIndustry: Medical Instruments & Supplies
Becton Dickinson and Co, formerly Becton Dickinson & Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The Company' s operations consist of three business segments: BD Medical, BD Diagnostics and BD Biosciences. On February 9, 2012, the Company acquired a 100% interest in KIESTRA Lab Automation BV. On August 24, 2012, the Company acquired a 100% interest in Sirigen Group Limited. On October 31, 2012, the Company sold its BD Biosciences -Discovery Labware unit. In December 2012, the Company acquired Safety Syringes, Inc. Effective March 12, 2013, the Company acquired Cato Software Solutions GmbH.
Did you know?
Profit margin stands at 8.0%.
Current Price
$154.51
-1.17%GoodMoat Value
$146.37
5.3% overvaluedProfile
Valuation (TTM)
Market Cap$44.10B
P/E25.10
EV$63.09B
P/B1.74
Shares Out285.42M
P/Sales2.01
Revenue$21.92B
EV/EBITDA12.40
Becton Dickinson & Company (BDX) Stock News
BDX Stock News & Headlines
Latest stock news and headlines for Becton Dickinson & Company (BDX). Stay informed on earnings reports, analyst upgrades and downgrades, market-moving events, and company announcements.
Current stock price: $154.51. Market cap: $44.10B. Sector: Healthcare. Industry: Medical Instruments & Supplies. This page aggregates the latest news articles relevant to BDX from financial news sources, helping investors stay current on events that may impact Becton Dickinson & Company's stock price.
News catalysts can drive significant short-term price movement. Earnings surprises, management changes, product launches, regulatory decisions, and analyst coverage changes all create opportunities and risks. Combine news monitoring with GoodMoat's fundamental analysis, quality scores, and valuation tools for a complete research workflow on Becton Dickinson & Company (BDX).